Category: Pharmacy and Medication Savings - Page 2

Recent Patent Cases and Generic Delays: 2023-2025 Examples

Recent Patent Cases and Generic Delays: 2023-2025 Examples

Despite FDA approval, generic drugs in the U.S. face average delays of 3.2 years due to patent litigation, with complex drugs and oncology treatments hit hardest. Learn how patent thickets, the 30-month stay, and supply chain issues block affordable access.

Immunosuppressants: Cyclosporine and Tacrolimus Generic Issues

Immunosuppressants: Cyclosporine and Tacrolimus Generic Issues

Cyclosporine and tacrolimus are critical immunosuppressants for transplant patients. Generic versions save money but carry risks due to narrow therapeutic index. Learn how switching brands can affect drug levels, cause rejection, and what steps to take to stay safe.

NTI Substitution Laws: Which States Block Generic Drug Swaps

NTI Substitution Laws: Which States Block Generic Drug Swaps

Twenty-seven U.S. states have special rules blocking or restricting generic substitution for narrow therapeutic index drugs like warfarin and levothyroxine. Know which states restrict swaps, why it matters, and how to protect yourself.